149 related articles for article (PubMed ID: 36152045)
1. Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.
Maimaitiaili Y; Fukumura Y; Hirabayashi K; Kinowaki Y; Naito Y; Saito A; Rong L; Nakahodo J; Yao T
Virchows Arch; 2022 Dec; 481(6):865-876. PubMed ID: 36152045
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.
Singhi AD; Wood LD; Parks E; Torbenson MS; Felsenstein M; Hruban RH; Nikiforova MN; Wald AI; Kaya C; Nikiforov YE; Favazza L; He J; McGrath K; Fasanella KE; Brand RE; Lennon AM; Furlan A; Dasyam AK; Zureikat AH; Zeh HJ; Lee K; Bartlett DL; Slivka A
Gastroenterology; 2020 Feb; 158(3):573-582.e2. PubMed ID: 31678302
[TBL] [Abstract][Full Text] [Related]
3. Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.
Itoh T; Omori Y; Seino M; Hirose K; Date F; Ono Y; Mizukami Y; Aoki S; Ishida M; Mizuma M; Morikawa T; Higuchi R; Honda G; Okamura Y; Kinoshita K; Unno M; Furukawa T
Mod Pathol; 2024 Jan; 37(1):100358. PubMed ID: 37871652
[TBL] [Abstract][Full Text] [Related]
4. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
[TBL] [Abstract][Full Text] [Related]
5. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
6. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of follistatin and low apoptotic activity in intraductal oncocytic papillary neoplasm of the pancreatobiliary system.
Nakahodo J; Fukumura Y; Saito T; Hirabayashi K; Doi R; Hayashi T; Yao T
Sci Rep; 2020 May; 10(1):8179. PubMed ID: 32424306
[TBL] [Abstract][Full Text] [Related]
8. Intraductal oncocytic papillary neoplasm (IOPN): two case reports and review of the literature.
Innocenti L; Rotondo MI; Donati F; Boggi U; Campani D
Transl Cancer Res; 2023 Mar; 12(3):663-672. PubMed ID: 37033351
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract][Full Text] [Related]
10. CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.
Mattiolo P; Hong SM; Paolino G; Rusev BC; Marchegiani G; Salvia R; Andrianello S; Capelli P; Piccoli P; Parolini C; Scarpa A; Lawlor RT; Luchini C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806726
[TBL] [Abstract][Full Text] [Related]
11. Fundic gland differentiation of oncocytic/pancreatobiliary subtypes of pancreatic intraductal papillary mucinous neoplasm.
Mamat O; Fukumura Y; Saito T; Takahashi M; Mitomi H; Sai JK; Kawasaki S; Yao T
Histopathology; 2016 Oct; 69(4):570-81. PubMed ID: 26990132
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET Findings of Intraductal Oncocytic Papillary Neoplasms of the Pancreas: Two Case Reports.
Kato T; Ikari S; Hirata K; Machida T; Nakamura H; Meguro T; Morita T; Takahashi T; Tamaki N; Horita S
Case Rep Gastroenterol; 2012 May; 6(2):415-24. PubMed ID: 22933987
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
Adsay NV; Longnecker DS; Klimstra DS
Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
[TBL] [Abstract][Full Text] [Related]
14. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis.
Basturk O; Khayyata S; Klimstra DS; Hruban RH; Zamboni G; Coban I; Adsay NV
Am J Surg Pathol; 2010 Mar; 34(3):364-70. PubMed ID: 20139757
[TBL] [Abstract][Full Text] [Related]
15. Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas.
Pea A; Paolino G; Martelli F; Bariani E; Piccoli P; Sereni E; Salvia R; Lawlor RT; Cheng L; Chang D; Scarpa A; Luchini C
Virchows Arch; 2023 Aug; 483(2):157-165. PubMed ID: 37086293
[TBL] [Abstract][Full Text] [Related]
16. Intraductal Oncocytic Papillary Neoplasms of the Pancreas.
Kallen ME; Naini BV
Arch Pathol Lab Med; 2016 Sep; 140(9):992-6. PubMed ID: 27575268
[TBL] [Abstract][Full Text] [Related]
17. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
[TBL] [Abstract][Full Text] [Related]
18. Intraductal oncocytic papillary neoplasm of the pancreas: clinical and radiological features compared to those of intraductal papillary mucinous neoplasm.
Nakaya M; Nakai Y; Takahashi M; Fukukura Y; Sato K; Kameda A; Tashiro Y; Kageyama S; Sofue K; Nakano T; Yoshimitsu K; Marugami N; Takeyama N; Tanaka M; Hasegawa K; Watadani T
Abdom Radiol (NY); 2023 Aug; 48(8):2483-2493. PubMed ID: 37358603
[TBL] [Abstract][Full Text] [Related]
19. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features.
Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y
Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918
[TBL] [Abstract][Full Text] [Related]
20. Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS -Mutant and GNAS -Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Omori Y; Ono Y; Morikawa T; Motoi F; Higuchi R; Yamamoto M; Hayakawa Y; Karasaki H; Mizukami Y; Unno M; Furukawa T
Ann Surg; 2023 Feb; 277(2):e384-e395. PubMed ID: 33914475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
